This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
See Cramer's multi-million dollar portfolio for FREE and get his new book Get Rich Carefully! Learn More

IntegraMed America Presentation At Oppenheimer Healthcare Conference - Transcript

IntegraMed America (INMD)

Presentation at Oppenheimer Healthcare Conference

December 14, 2011 2:10 p.m. ET

Executives

Jay Higham - CEO

Analysts

Matt [Nuremberg] - Oppenheimer

Presentation

Matt [Nuremberg]

Welcome to the 22nd Annual Healthcare Conference. I’m Matt [Nuremberg] with the Healthcare Services Team, and I’d like to introduce IntegraMed. We have with us from the company, CEO Jay Higham.

Jay Higham

Thank you very much. Thanks to Oppenheimer for inviting us to this conference. We appreciate being here. I’m going to take a few minutes to walk through this slide deck and try to leave some time at the end for people to ask questions.

IntegraMed is a healthcare services company. We were founded in 1985, so we’re very well established in the United States. We operate in two highly fragmented segments of healthcare, the fertility services field and the varicose vein treatment.

On a combined basis, these two verticals represent about a $6 billion market in the United States, and IntegraMed is the largest provider in both those two segments. We have very little national competition. Both of them are very competitive in each local market, but from a national level there’s nobody that’s doing quite what we do.

We do have that national footprint, and we have rapid growth really driven three ways, through patient acquisition; through de novo new clinic openings, where we’re launching new clinics in major markets across the country; and also in strategic acquisitions. And we have a strong track record in all three components of the growth. That’s resulted over the last five years in compound average top line growth approaching 14% and EBITDA just over 14%.

Stock quotes in this article: INMD 

Select the service that is right for you!

COMPARE ALL SERVICES
Action Alerts PLUS
Try it NOW

Jim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
  • Weekly roundups
TheStreet Quant Ratings
Try it NOW
Only $49.95/yr

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
  • Upgrade/downgrade alerts
Stocks Under $10
Try it NOW

David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
  • Weekly roundups
Dividend Stock Advisor
Try it NOW

Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Alerts when market news affect the portfolio
  • Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
Real Money Pro
Try it NOW

All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.

Product Features:
  • Real Money + Doug Kass Plus 15 more Wall Street Pros
  • Intraday commentary & news
  • Ultra-actionable trading ideas
Options Profits
Try it NOW

Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • 100+ monthly options trading ideas
  • Actionable options commentary & news
  • Real-time trading community
  • Options TV
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
DOW 16,424.85 +162.29 1.00%
S&P 500 1,862.31 +19.33 1.05%
NASDAQ 4,086.2250 +52.0640 1.29%

Brokerage Partners

Rates from Bankrate.com

  • Mortgage
  • Credit Cards
  • Auto
Advertising Partners

Free Newsletters from TheStreet

My Subscriptions:

After the Bell

Before the Bell

Booyah! Newsletter

Midday Bell

TheStreet Top 10 Stories

Winners & Losers

Register for Newsletters
Top Rated Stocks Top Rated Funds Top Rated ETFs